Clinical Trial Update: Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the impact of Xuesaitong Soft Capsules on major risk factors in patients with coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Xuesaitong Soft Capsules

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Heart Disease | Phase 4 | Status: RECRUITING